These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 23603981)
21. Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography. Zhu XD; Zhang JB; Fan PL; Xiong YQ; Zhuang PY; Zhang W; Xu HX; Gao DM; Kong LQ; Wang L; Wu WZ; Tang ZY; Ding H; Sun HC BMC Cancer; 2011 Jan; 11():28. PubMed ID: 21251271 [TBL] [Abstract][Full Text] [Related]
22. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy. Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434 [TBL] [Abstract][Full Text] [Related]
23. AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus. Gadalla AE; Pearson T; Currie AJ; Dale N; Hawley SA; Sheehan M; Hirst W; Michel AD; Randall A; Hardie DG; Frenguelli BG J Neurochem; 2004 Mar; 88(5):1272-82. PubMed ID: 15009683 [TBL] [Abstract][Full Text] [Related]
24. AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase. Kefas BA; Heimberg H; Vaulont S; Meisse D; Hue L; Pipeleers D; Van de Casteele M Diabetologia; 2003 Feb; 46(2):250-4. PubMed ID: 12627324 [TBL] [Abstract][Full Text] [Related]
25. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine. Gong YF; Srinivas RV; Fridland A Mol Pharmacol; 1993 Jul; 44(1):30-6. PubMed ID: 8341276 [TBL] [Abstract][Full Text] [Related]
26. Herbal extract "Songyou Yin" inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential. Huang XY; Wang L; Huang ZL; Zheng Q; Li QS; Tang ZY J Cancer Res Clin Oncol; 2009 Sep; 135(9):1245-55. PubMed ID: 19277711 [TBL] [Abstract][Full Text] [Related]
27. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway. Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627 [TBL] [Abstract][Full Text] [Related]
28. Anticancer effect of tert-butyl-2(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2)-pyrrolidine-1-carboxylic ester on human hepatoma HepG2 cell line. Guo J; Zhang Y; Zhang J; Liang J; Zeng L; Guo G Chem Biol Interact; 2012 Jul; 199(1):38-48. PubMed ID: 22704995 [TBL] [Abstract][Full Text] [Related]
29. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression. Zhou H; Fu LX; Li L; Chen YY; Zhu HQ; Zhou JL; Lv MX; Gan RZ; Zhang XX; Liang G J Ethnopharmacol; 2020 Oct; 261():113118. PubMed ID: 32621953 [TBL] [Abstract][Full Text] [Related]
30. The use of 5-aminoimidazole-4-carboxamide riboside (AICA riboside) to improve random skin flap viability in the rat model. Salerno GM; McBride DM; Bleicher JN Ann Plast Surg; 1991 Jun; 26(6):544-50. PubMed ID: 1883160 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Cui W; Yu CH; Hu KQ Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255 [TBL] [Abstract][Full Text] [Related]
32. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis. Du J; Sun Y; Lu YY; Lau E; Zhao M; Zhou QM; Su SB Anticancer Res; 2017 Nov; 37(11):6141-6151. PubMed ID: 29061795 [TBL] [Abstract][Full Text] [Related]
33. Insulinotropic action of AICA riboside. II. Secretory, metabolic and cationic aspects. Malaisse WJ; Conget I; Sener A; Rorsman P Diabetes Res; 1994; 25(1):25-37. PubMed ID: 7648779 [TBL] [Abstract][Full Text] [Related]
34. Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid. Li ZY; Yin YF; Guo Y; Li H; Xu MQ; Liu M; Wang JR; Feng ZH; Duan XC; Zhang S; Zhang SQ; Wang GX; Liao A; Wang SM; Zhang X Int J Nanomedicine; 2020; 15():1809-1821. PubMed ID: 32214813 [TBL] [Abstract][Full Text] [Related]
35. Effect of 5-amino-4-imidazolecarboxamide riboside (AICA-riboside) on the purine nucleotide synthesis and growth of rat kidney cells in culture: study with [15N]aspartate. Nissim I; Yudkoff M; Nissim I; States B J Cell Physiol; 1989 Mar; 138(3):536-40. PubMed ID: 2925797 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of mast cell mediator release by 5-amino-4-imidazolecarboxamide riboside. Marquardt DL; Gruber HE Biochem Pharmacol; 1986 Dec; 35(24):4415-21. PubMed ID: 2947580 [TBL] [Abstract][Full Text] [Related]
37. AICA-riboside (acadesine), an activator of AMP-activated protein kinase with potential for application in hematologic malignancies. Van Den Neste E; Van den Berghe G; Bontemps F Expert Opin Investig Drugs; 2010 Apr; 19(4):571-8. PubMed ID: 20367195 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide. Baggott JE; Vaughn WH; Hudson BB Biochem J; 1986 May; 236(1):193-200. PubMed ID: 2431676 [TBL] [Abstract][Full Text] [Related]
39. In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice. Jin M; Shen X; Zhao C; Qin X; Liu H; Huang L; Qiu Z; Liu Y Drug Deliv; 2013; 20(3-4):127-33. PubMed ID: 23731485 [TBL] [Abstract][Full Text] [Related]
40. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma. Wang Y; Liu Y; Liu Y; Zhou W; Wang H; Wan G; Sun D; Zhang N; Wang Y Int J Pharm; 2015 Apr; 483(1-2):89-100. PubMed ID: 25681730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]